COH - Cochlear Limited
ASX
->
Healthcare
->
Medical Devices
Sydney,
Australia
Type: Equity
COH price evolution
COH
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $485.2 | $485.2 | $555.5 | $555.5 |
| Short term investments | ||||
| Net receivables | $453.8 | $453.8 | $457.5 | $457.5 |
| Inventory | $321.5 | $321.5 | $311.5 | $311.5 |
| Total current assets | $1327.4 | $1327.4 | $1361.5 | $1361.5 |
| Long term investments | $155.2 | $155.2 | $188.1 | $188.1 |
| Property, plant & equipment | $455.9 | $455.9 | $447.2 | $447.2 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2530.5 | $2530.5 | $2568.7 | $2568.7 |
| Current liabilities | ||||
| Accounts payable | $247.1 | $247.1 | $270.4 | $270.4 |
| Deferred revenue | ||||
| Short long term debt | $39.8 | $39.8 | $39.2 | $39.2 |
| Total current liabilities | $517.4 | $517.4 | $578 | $578 |
| Long term debt | $166.9 | $166.9 | $162.6 | $162.6 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $748.7 | $748.7 | $819.9 | $819.9 |
| Shareholders' equity | ||||
| Retained earnings | $632.1 | $632.1 | $555.4 | $555.4 |
| Other shareholder equity | -$54.5 | -$54.5 | -$43 | -$43 |
| Total shareholder equity | $1781.8 | $1781.8 | $1748.8 | $1748.8 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $555.5 | $629.3 | $609.6 | $565 |
| Short term investments | $365 | |||
| Net receivables | $457.5 | $390.4 | $365.5 | $304.9 |
| Inventory | $311.5 | $270.2 | $216.1 | $223.8 |
| Total current assets | $1361.5 | $1327 | $1230 | $1477.5 |
| Long term investments | $188.1 | $119.1 | $199.5 | $94.9 |
| Property, plant & equipment | $447.2 | $439.2 | $428.5 | $438.8 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2568.7 | $2465.1 | $2438.2 | $2575.7 |
| Current liabilities | ||||
| Accounts payable | $270.4 | $232.4 | $202.9 | $159.3 |
| Deferred revenue | ||||
| Short long term debt | $39.2 | $78.7 | $31.9 | $419.1 |
| Total current liabilities | $578 | $527.6 | $402.5 | $817.5 |
| Long term debt | $162.6 | $175.2 | $232.4 | $285.4 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $819.9 | $779.4 | $736.5 | $1174.2 |
| Shareholders' equity | ||||
| Retained earnings | $555.4 | $455.3 | $435.6 | $174.4 |
| Other shareholder equity | -$43 | -$46.2 | -$48.3 | -$42.4 |
| Total shareholder equity | $1748.8 | $1685.7 | $1701.7 | $1401.5 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $549.25 | $549.25 | $525.45 | $525.45 |
| Cost of revenue | $142.9 | $142.9 | $130.55 | $130.55 |
| Gross Profit | $406.35 | $406.35 | $394.9 | $394.9 |
| Operating activities | ||||
| Research & development | $63.65 | $63.65 | $71.15 | $71.15 |
| Selling, general & administrative | $216 | $216 | $220.75 | $220.75 |
| Total operating expenses | $419.8 | $419.8 | $419.05 | $419.05 |
| Operating income | $129.45 | $129.45 | $106.4 | $106.4 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $34.3 | $34.3 | $24.95 | $24.95 |
| Interest expense | -$2.15 | -$2.15 | -$2.35 | -$2.35 |
| Net income | ||||
| Net income | $95.7 | $95.7 | $79.5 | $79.5 |
| Income (for common shares) | $95.7 | $95.7 | $79.5 | $79.5 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1936.1 | $1648.3 | $1497.6 | $1320.6 |
| Cost of revenue | $488 | $411 | $398.7 | $336.2 |
| Gross Profit | $1448.1 | $1237.3 | $1098.9 | $984.4 |
| Operating activities | ||||
| Research & development | $244.9 | $210.7 | $195 | $185.1 |
| Selling, general & administrative | $810.4 | $657.7 | $556.3 | $563.8 |
| Total operating expenses | $1529.8 | $1267.4 | $1123.5 | $1582.8 |
| Operating income | $406.3 | $380.9 | $374.1 | -$262.2 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $96 | $104.7 | $39.2 | -$32.8 |
| Interest expense | -$9.4 | -$8.6 | -$34.5 | -$1.7 |
| Net income | ||||
| Net income | $300.6 | $289.1 | $326.5 | -$238.3 |
| Income (for common shares) | $300.6 | $289.1 | $326.5 | -$238.3 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $95.7 | $95.7 | $79.5 | $79.5 |
| Operating activities | ||||
| Depreciation | $21.55 | $21.55 | $12.6 | $12.6 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $78.55 | $78.55 | $136.65 | $136.65 |
| Investing activities | ||||
| Capital expenditures | -$11.3 | -$11.3 | -$14.85 | -$14.85 |
| Investments | ||||
| Total cash flows from investing | -$23.9 | -$23.9 | -$20.05 | -$20.05 |
| Financing activities | ||||
| Dividends paid | -$57.35 | -$57.35 | -$51 | -$51 |
| Sale and purchase of stock | -$21.45 | -$21.45 | -$14.8 | -$14.8 |
| Net borrowings | -$8.65 | -$8.65 | -$28.7 | -$28.7 |
| Total cash flows from financing | -$88.7 | -$88.7 | -$99.85 | -$99.85 |
| Effect of exchange rate | -$1.8 | -$1.8 | -$1.2 | -$1.2 |
| Change in cash and equivalents | -$35.15 | -$35.15 | $16.9 | $16.9 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2019 |
|---|---|---|---|---|
| Net income | $300.6 | $289.1 | $323.8 | |
| Operating activities | ||||
| Depreciation | $62.5 | $64.5 | $56.9 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $362.4 | $376.5 | $265.4 | $296 |
| Investing activities | ||||
| Capital expenditures | -$50 | -$44.5 | -$41.2 | -$114.6 |
| Investments | ||||
| Total cash flows from investing | -$125.7 | -$138.9 | $279.9 | -$137.8 |
| Financing activities | ||||
| Dividends paid | -$197.4 | -$194 | -$75.6 | -$181.8 |
| Sale and purchase of stock | -$29.6 | $2.4 | $7.4 | |
| Net borrowings | -$72.7 | -$25.6 | -$421.9 | $33.5 |
| Total cash flows from financing | -$310.4 | -$220.7 | -$495.1 | -$140.9 |
| Effect of exchange rate | -$10.2 | $0.1 | -$15.8 | -$0.2 |
| Change in cash and equivalents | -$73.8 | $19.7 | $44.6 | $17.1 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $2.15B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $350.40M |
| Revenue Q/Q | 24.10% |
| Revenue Y/Y | 25.49% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 13.74% |
| ROE | 19.85% |
| Debt/Equity | 0.47 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.57 |
| Quick ratio | 1.94 |